Drug Trial Radar · NCT07915791
A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
279
Planned (sponsor's estimate)
Start
Oct 29, 2026
Primary completion
Mar 7, 2029
Study completion Feb 6, 2030
Sponsor
- Lead sponsor
- GlaxoSmithKlineGSK (GSK)
- Sponsor type
- Industry
- First posted
- Nov 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is for adult participants with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who continue to experience exacerbations despite standard of care triple therapy treatment. It will assess the effectiveness and safety of two investigational drugs, GSK3862995B and GSK5784283, given together compared to a placebo in addition to standard of care.
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
GSK3862995BDrug
Participants will receive GSK3862995B.
GSK5784283Drug
Participants will receive GSK5784283.
PlaceboDrug
Participants will receive matching Placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Moderate/severe Exacerbations in Former SmokersTime frame: Up to 72 weeks
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
GSK Investigational Site
Newport Beach, California · Recruiting
GSK Investigational Site
Miami, Florida · Recruiting
GSK Investigational Site
Derby, Kansas · Recruiting
GSK Investigational Site
Columbia, Maryland · Recruiting
GSK Investigational Site
Oklahoma City, Oklahoma · Recruiting
GSK Investigational Site
Philadelphia, Pennsylvania · Recruiting
GSK Investigational Site
Rock Hill, South Carolina · Recruiting
GSK Investigational Site
Tomball, Texas · Recruiting
GSK Investigational Site
Bradford, United Kingdom · Recruiting
GSK Investigational Site
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.